Gene · 862
Papers4,591
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
2,261 to 2,280 of 4,591
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The novel BET bromodomain inhibitor BI 894999 represses super-enhancer-associated transcription and synergizes with CDK9 inhibition in AML. | Oncogene | 2018 | 29491412 | PubTator, text mining | PubMed |
| Leptomeninges-Derived Induced Pluripotent Stem Cells and Directly Converted Neurons From Autopsy Cases With Varying Neuropathologic Backgrounds. | J Neuropathol Exp Neurol | 2018 | 29474672 | PubTator, text mining | PubMed |
| Epigenetic heterogeneity affects the risk of relapse in children with t(8;21)RUNX1-RUNX1T1-rearranged AML. | Leukemia | 2018 | 29472719 | PubTator, text mining | PubMed |
| Clinical relevance of IDH1/2 mutant allele burden during follow-up in acute myeloid leukemia. A study by the French ALFA group. | Haematologica | 2018 | 29472349 | PubTator, text mining | PubMed |
| Combined cistrome and transcriptome analysis of SKI in AML cells identifies SKI as a co-repressor for RUNX1. | Nucleic Acids Res | 2018 | 29471413 | PubTator, text mining | PubMed |
| Targeting Leukemia Stem Cells in the Bone Marrow Niche. | Biomedicines | 2018 | 29466292 | PubTator, text mining | PubMed |
| SNP-array lesions in core binding factor acute myeloid leukemia. | Oncotarget | 2018 | 29464086 | PubTator, text mining | PubMed |
| The Airway Transcriptome as a Biomarker for Early Lung Cancer Detection. | Clin Cancer Res | 2018 | 29463557 | PubTator, text mining | PubMed |
| Improving stability of prediction models based on correlated omics data by using network approaches. | PLoS One | 2018 | 29462177 | PubTator, text mining | PubMed |
| Modeling the human bone marrow niche in mice: From host bone marrow engraftment to bioengineering approaches. | J Exp Med | 2018 | 29453226 | PubTator, text mining | PubMed |
| Specific or not specific recruitment of DNMTs for DNA methylation, an epigenetic dilemma. | Clin Epigenetics | 2018 | 29449903 | PubTator, text mining | PubMed |
| Transcriptional repression of DNA repair genes is a hallmark and a cause of cellular senescence. | Cell Death Dis | 2018 | 29449545 | PubTator, text mining | PubMed |
| Acute myeloid/T-lymphoblastic leukaemia (AMTL): a distinct category of acute leukaemias with common pathogenesis in need of improved therapy. | Br J Haematol | 2018 | 29441563 | PubTator, text mining | PubMed |
| A novel miR-375-HOXB3-CDCA3/DNMT3B regulatory circuitry contributes to leukemogenesis in acute myeloid leukemia. | BMC Cancer | 2018 | 29439669 | PubTator, text mining | PubMed |
| The zebrafish: A fintastic model for hematopoietic development and disease. | Wiley Interdiscip Rev Dev Biol | 2018 | 29436122 | PubTator, text mining | PubMed |
| Inhibition of X-linked inhibitor of apoptosis protein enhances anti-tumor potency of pure total flavonoids on the growth of leukemic cells. | Exp Ther Med | 2018 | 29434799 | PubTator, text mining | PubMed |
Combined usage of Wilms' tumor gene quantitative analysis and multiparameter flow cytometry for minimal residual disease monitoring of acute myeloid leukemia patients after allogeneic hematopoietic stem cells transplantation. | Exp Ther Med | 2018 | 29434724 | PubTator, text mining | PubMed |
| CRISPR-Cas9: a promising genetic engineering approach in cancer research. | Ther Adv Med Oncol | 2018 | 29434679 | PubTator, text mining | PubMed |
| C/EBPα overrides epigenetic reprogramming by oncogenic transcription factors in acute myeloid leukemia. | Blood Adv | 2018 | 29431622 | PubTator, text mining | PubMed |
| Distinct genetic alteration profiles of acute myeloid leukemia between Caucasian and Eastern Asian population. | J Hematol Oncol | 2018 | 29427994 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/862/papers?page=114